Moreover, taking into account our previously published data concerning the capacity of MOXI to interact with Mcl-1 protein [10], we have demonstrated that the analyzed fluoroquinolone derivative and MIM1 used in a two-component model exerted a potential synergistic mode of action towards MDA-MB-231 breast cancer cells. The gene discussed is MCL1; the disease is breast carcinoma.